Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00759252 · ClinicalTrials.gov registry record

Perceptions Regarding Investigational Screening for Memory Problems in Primary Care

A clinical trial, sponsored by Indiana University.

Completed
Registry status
954
Enrollment target

NCT00759252: Completed study, sponsored by Indiana University.

NCT00759252 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 954 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00759252 has completed, sponsored by Indiana University.

COMPLETED
Registry status
954 participants
Enrollment target

Study Summary

The purpose of this study is to conduct a cross-sectional survey of primary care patients to better understand their perceptions of the risks and benefits of a screen and subsequent diagnostic confirmation of dementia.

Trial Details

FieldValue
Enrollment Target 954 participants
Start Date 2008-02
Est. Completion 2011-05
Indiana University

890 total trials

What the finished NCT00759252 record still lists

NCT00759252 is an observational study that tracks outcomes without assigning an intervention. The registered 954 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00759252 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00759252 about?

NCT00759252 is a clinical study titled "Perceptions Regarding Investigational Screening for Memory Problems in Primary Care". The purpose of this study is to conduct a cross-sectional survey of primary care patients to better understand their perceptions of the risks and benefits of a screen and subsequent diagnostic confirmation of dementia.

What is the current status of trial NCT00759252?

This trial is currently completed. The enrollment target is 954 participants. The study started on 2008-02. Estimated completion is 2011-05.

Who is sponsoring clinical trial NCT00759252?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06225596 · 956 participants · Phase 2

    Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

  • NCT04375033 · 952 participants · Phase 4

    A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

  • NCT06259669 · 958 participants

    Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

  • NCT03784924 · 950 participants

    EDRN Prostate MRI Biomarker Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00759252, the US trial registry maintained by the National Library of Medicine. NCT00759252 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.